clenbuterol has been researched along with methylprednisolone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Borghetti, A; Cacciani, G; Coffrini, E; Fiaccadori, E; Fracchia, C; Rampulla, C; Ronda, N; Vezzani, A | 1 |
3 other study(ies) available for clenbuterol and methylprednisolone
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Hypophosphatemia in course of chronic obstructive pulmonary disease. Prevalence, mechanisms, and relationships with skeletal muscle phosphorus content.
Topics: Adult; Aged; Aged, 80 and over; Carbon Dioxide; Clenbuterol; Female; Furosemide; Humans; Kidney; Lung Diseases, Obstructive; Male; Methylprednisolone; Middle Aged; Muscles; Oxygen; Phosphorus; Theophylline | 1990 |